Visum Pharmaceutical Co., Ltd. was established in June 2010, it is an integrated pharmaceutical enterprise specialized in research and development, production and marketing of various oral solid drugs for US and China market. Our facility has been inspected 3 times by US FDA and 4 times by Chinese NMPA in the past 5 years. Currently 3 products manufactured by Visum are being marketed in US with total of more than 400 million tablets exported to the US market in 2021. The company is specialised in producing oral solid, half-solid and liquid pharmaceutical products which are with high technical barriers. Visum offer our customers with one-stop CDMO platform with various customization services , assisting domestic and international customers to market in China, U.S., EU and WHO.